Cognition Therapeutics, Inc. (CGTX)
0.6988
-0.01
(-1.52%)
USD |
NASDAQ |
Nov 03, 16:00
0.6988
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics Enterprise Value : 33.28M for Nov. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 33.28M |
| October 30, 2026 | 32.20M |
| October 29, 2026 | 36.11M |
| October 28, 2026 | 37.02M |
| October 27, 2026 | 37.98M |
| October 26, 2026 | 31.88M |
| October 23, 2026 | 34.15M |
| October 22, 2026 | 32.42M |
| October 21, 2026 | 36.80M |
| October 20, 2026 | 35.58M |
| October 19, 2026 | 34.97M |
| October 16, 2026 | 35.20M |
| October 15, 2026 | 35.46M |
| October 14, 2026 | 39.66M |
| October 13, 2026 | 42.03M |
| October 12, 2026 | 47.28M |
| October 09, 2026 | 49.18M |
| October 08, 2026 | 50.92M |
| October 07, 2026 | 54.86M |
| October 06, 2026 | 55.18M |
| October 05, 2026 | 55.00M |
| October 02, 2026 | 53.76M |
| October 01, 2026 | 50.54M |
| September 30, 2026 | 57.08M |
| September 29, 2026 | 56.55M |
| Date | Value |
|---|---|
| September 28, 2026 | 55.03M |
| September 25, 2026 | 54.85M |
| September 24, 2026 | 56.21M |
| September 23, 2026 | 56.13M |
| September 22, 2026 | 59.11M |
| September 21, 2026 | 60.88M |
| September 18, 2026 | 64.68M |
| September 17, 2026 | 66.59M |
| September 16, 2026 | 62.78M |
| September 15, 2026 | 64.21M |
| September 14, 2026 | 61.83M |
| September 11, 2026 | 59.25M |
| September 10, 2026 | 58.95M |
| September 09, 2026 | 59.93M |
| September 08, 2026 | 61.83M |
| September 04, 2026 | 63.73M |
| September 03, 2026 | 65.64M |
| September 02, 2026 | 65.64M |
| September 01, 2026 | 61.83M |
| August 31, 2026 | 63.73M |
| August 28, 2026 | 62.78M |
| August 27, 2026 | 66.59M |
| August 26, 2026 | 65.64M |
| August 25, 2026 | 63.73M |
| August 24, 2026 | 59.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Bristol Myers Squibb Co. | 161.04B |
| ANI Pharmaceuticals, Inc. | 1.858B |
| Corcept Therapeutics, Inc. | 8.385B |
| Veru, Inc. | 13.72M |
| Johnson & Johnson | 678.69B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.932M |
| Total Expenses (Quarterly) | 3.932M |
| EPS Diluted (Quarterly) | -0.0434 |
| Earnings Yield | -27.96% |
| Normalized Earnings Yield | -27.98 |